Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Appointed director
Quarterly results
Director departure
Inv. presentation
China Biologic Products Holdings, Inc. (CBPO) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/12/2023 SC 13D/A Parfield International Ltd reports a 0% stake in China Biologic Products Holdings, Inc.
05/02/2023 CT ORDER Form CT ORDER - Confidential treatment order:
04/30/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
04/22/2021 SC 13D/A Parfield International Ltd reports a 0% stake in China Biologic Products Holdings, Inc.
04/22/2021 SC 13D/A HHLR ADVISORS, LTD. reports a 0% stake in China Biologic Products Holdings, Inc.
04/22/2021 SC 13D/A Centurium Capital Partners 2018, L.P. reports a 0% stake in China Biologic Products Holdings, Inc.
04/22/2021 SC 13D/A Chow Joseph reports a 0% stake in China Biologic Products Holdings, Inc.
04/22/2021 SC 13D/A CITIC Capital Holdings Ltd reports a 0% stake in China Biologic Products Holdings, Inc.
04/21/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/21/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/21/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/21/2021 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
04/20/2021 6-K Quarterly results
04/20/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/29/2021 6-K Quarterly results
03/01/2021 6-K Quarterly results
01/25/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"China Biologic Products Holdings, Inc."
01/25/2021 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
01/15/2021 SC 13D CPEChina Fund III, L.P. reports a 9.7% stake in China Biologic Products Holdings, Inc.
01/14/2021 SC 13D/A Parfield International Ltd reports a 5.5% stake in China Biologic Products Holdings, Inc.
01/14/2021 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
01/08/2021 SC 13D/A Chow Joseph reports a 13.8% stake in China Biologic Products Holdings, Inc.
01/08/2021 SC 13D/A PW Medtech Group Ltd reports a 0% stake in China Biologic Products Holdings, Inc.
01/07/2021 6-K Quarterly results
01/04/2021 SC 13D/A Parfield International Ltd reports a 5.5% stake in China Biologic Products Holdings, Inc.
12/31/2020 SC 13D/A Chow Joseph reports a 3.8% stake in China Biologic Products Holdings, Inc.
12/31/2020 SC 13D/A Centurium Capital Partners 2018, L.P. reports a 25.6% stake in China Biologic Products Holdings, Inc.
12/31/2020 SC 13D/A PW Medtech Group Ltd reports a 9.7% stake in China Biologic Products Holdings, Inc.
12/31/2020 SC 13D/A CITIC Capital Holdings Ltd reports a 12.8% stake in China Biologic Products Holdings, Inc.
12/18/2020 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
11/25/2020 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
11/24/2020 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"China Biologic Reports Financial Results for the Third Quarter of 2020",
"China Biologic Third Quarter 2020 Financial Results"
11/23/2020 SC 13D/A Temasek Holdings Ltd reports a 3.2% stake in China Biologic Products Holdings, Inc.
11/23/2020 SC 13D/A HILLHOUSE CAPITAL ADVISORS, LTD. reports a 7.6% stake in China Biologic Products Holdings, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy